Table 1.
Baseline characteristics and perioperative outcomes according to 3-months IPAQ-SF levels
| LOW IPAQ-SF 127 pts | M-H IPAQ-SF 98 pts | p | |
|---|---|---|---|
| Age (year), median (range) | 67 (58–73) | 66 (57–73) | > 0.05 |
| BMI, median (range) | 25 (24–26) | 24 (23–26) | > 0.05 |
| Previous abdominal surgery, n (%) | 10/127 (8) | 8/98 (8) | > 0.05 |
| ASA score ≥ 2, n (%) | 4/127 (3) | 1/98 (1) | > 0.05 |
| POP-Q stage, median (range) | 3 (2–4) | 3 (2–4) | > 0.05 |
| POPDI-6, median (range) | 43 (35–54) | 46 (43–58) | > 0.05 |
| PISQ-12, median (range) | 42 (33–51) | 39 (31–50) | > 0.05 |
| Intraoperative complications, n (%) | 0/127 (0) | 1/98 (1) | > 0.05 |
| EBL (ml), median (range) | 50 (30–60) | 60 (20–70) | > 0.05 |
| Hospitalization (days), median (range) | 2 (2–3) | 2 (2–3) | > 0.05 |
| Postoperative complications, n (%) | 4/127 (3) | 3/98 (3) | > 0.05 |
Range, percentile range (25th–75th); BMI, body mass index; ASA score, American Society of Anesthesiologists score; POP-Q stage: Pelvic Organ Prolapse Quantification system scores; POPDI-6: “Pelvic Organ Prolapse Distress Inventory—6”; PISQ-12: “Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire—12”; EBL: estimated blood loss
Two-sided significance level set at p < 0.05